|
|
||||||||
ORIGINAL RESEARCH |



From the *Department of Obstetrics and Gynecology, Brigham and Women's Hospital, and
Department of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston;
Department of Obstetrics and Gynecology, Boston Medical Center, Boston University School of Medicine, Boston;
Genetics and Teratology Unit, Department of Pediatrics, Massachusetts General Hospital, Harvard Medical School, Boston; and ¶Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Address reprint requests to: Adam Wolfberg, MD, MPH, Department of OB/GYN, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115; e-mail: awolfberg{at}partners.org.
OBJECTIVE: To determine whether maternal rheumatologic disease is associated with an increased risk of adverse obstetric or neonatal outcomes.
METHODS: Using an institutional database, we identified all women with diagnosed rheumatologic disease (n = 114) who delivered a baby at our institution during a 33-month period. We compared the incidence of adverse obstetric and neonatal outcomes among these women with the incidence among women without rheumatologic diseases (n = 18,534).
RESULTS: Women with rheumatologic diseases were more likely to have preeclampsia than women without rheumatologic disease (8.8% versus 2.3%, P < .001) Women with rheumatologic diseases were also at increased risk of preterm delivery (15.2% versus 7.8%, P = .002) and small-for-gestational-age infants (8.0% versus 3.1%, P = .001) compared with women without rheumatologic disease.
CONCLUSION: The finding that women with rheumatologic diseases are at increased risk of adverse obstetric outcomes suggests a need for heightened clinical vigilance and further research into the common pathophysiologic correlates.
LEVEL OF EVIDENCE: II-2
This article has been cited by other articles:
![]() |
J. R. Barton and B. M. Sibai Prediction and Prevention of Recurrent Preeclampsia Obstet. Gynecol., August 1, 2008; 112(2): 359 - 372. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Dhar and R. J. Sokol Lupus and Pregnancy: Complex Yet Manageable Clin. Med. Res., December 1, 2006; 4(4): 310 - 321. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. V. F. Hviid HLA-G in human reproduction: aspects of genetics, function and pregnancy complications Hum. Reprod. Update, May 1, 2006; 12(3): 209 - 232. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Wolfberg, A. Lee-Parritz, A. J. Peller, and E. S. Lieberman Association of Rheumatologic Disease With Preeclampsia Obstet. Gynecol., November 1, 2004; 104(5): 1106 - 1106. [Full Text] [PDF] |
||||
![]() |
M. Jolly Association of Rheumatologic Disease With Preeclampsia Obstet. Gynecol., November 1, 2004; 104(5): 1105 - 1106. [Full Text] [PDF] |
||||
![]() |
Rheumatologic Disease Linked with Poor Obstetric Outcomes Journal Watch (General), June 25, 2004; 2004(625): 5 - 5. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |